T 1166/15 (Split influenza vaccines/NOVARTIS) of 19.02.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T116615.20190219
- Date of decision
- 19 February 2019
- Case number
- T 1166/15
- Online on
- 28 June 2019
- Petition for review of
- -
- Application number
- 06808431.8
- IPC class
- A61K 39/145A61K 39/39
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Changing Th1/Th2 balance in split influenza vaccines with adjuvants
- Applicant name
- Novartis Vaccines and Diagnostics S.r.l.
- Opponent name
- Glaxo Smithkline Biologicals S.A.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)
- Keywords
- Sufficiency of disclosure - (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.